中国中医药信息杂志2017，Vol.24Issue(10)：1-4,4.DOI:10.3969/j.issn.1005-5304.2017.10.001
维药新药治疗骨质疏松症的临床研究指导原则(草案)
Clinical Research Guidelines for Treatment of Osteoporosis with New Uyghur Medicine (Draft)
摘要
Abstract
In this study, retrospective multi-center study on medical records of Uyghur medicine diagnosis and treatment program of osteoporosis was done and demographic, diagnostic, therapeutic, efficacy evaluation and nursing data and other information were collected. The main and secondary disease manifestations of osteoporosis were analyzed inductively. Osteoporosis was divided into 2 types in Uyghur medicine field, which were abnormal Savda type and abnormal Balgham type. Uighur medicine syndrome type standards of osteoporosis were established. Treatment efficacy was evaluated according to bone pain, bone density, life quality, and improvement of clinical symptoms and Uyghur medical symptoms. On this basis, in accordance with the technical requirements of the national drug review, the study developed clinical research guidelines for the treatment of osteoporosis with new Uyghur medicine (draft).关键词
骨质疏松症/维吾尔医药/临床研究指导原则Key words
osteoporosis/Uyghur medicine/clinical research guidelines分类
医药卫生引用本文复制引用
阿不都外力•阿不都克里木,阿布都吉力力•阿布都艾尼,李攻戍,刘炳林,裴小静,周贝,斯拉甫•艾白,王平山,玉苏甫•买提努尔,莫合买提•乌斯曼,张宏,白连省,李金凤,李治建..维药新药治疗骨质疏松症的临床研究指导原则(草案)[J].中国中医药信息杂志,2017,24(10):1-4,4.基金项目
新疆维吾尔自治区科技计划(201333101) （201333101）
